NCT04794127 2026-02-18
TRABEPIO
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
Clinical Trials
16 trialsNCT05919147 2025-07-04
TRACE-1
Pennington Biomedical Research Center
Phase 2 Active not recruiting
NCT05013255 2025-04-08
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
West Virginia University
Phase 2 Recruiting
NCT02852486 2025-03-30
EDI-PIO
University of Campinas, Brazil
Phase 2 Completed
NCT02942758 2024-05-08
AML-ViVA
University Hospital Regensburg
Phase 2 Terminated
NCT04995978 2023-06-23
Insulin Resistance and Androgen Deprivation Therapy
St. Louis University
Phase 2 Withdrawn
NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT04867252 2021-09-13
Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase 2 Completed
NCT04883125 2021-05-12
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
Mansoura University
Phase 2 Completed
NCT01838317 2021-03-01
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT02347813 2020-06-23
Preventing Squamous Cell Skin Cancer
University of Rochester
Phase 2 Completed
NCT02889003 2018-03-22
PIO2STOP
Versailles Hospital
Phase 2 Unknown
NCT02852083 2018-01-18
ModuLung
University Hospital Regensburg
Phase 2 Unknown
NCT00951379 2016-04-06
Pioglitazone for Oral Premalignant Lesions
National Cancer Institute (NCI)
Phase 2 Terminated
NCT02687425 2016-02-22
SESPI
Tongji Hospital
Phase 2 Unknown
NCT00923949 2015-09-30
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated